Norwest Venture Partners
Nathan focuses on growth equity investments in healthcare, including healthcare services, pharma services, healthcare IT, medical devices, and digital health. Nathan is actively involved with Norwest’s investments in American Endovascular & Amputation Prevention, Elligo Health Research, Kyo, Mindful Health Solutions, and RiverMend Health.
Before joining Norwest, Nathan was an analyst in the healthcare investment banking group at J.P. Morgan in San Francisco. In this role, he advised companies across the healthcare sector on mergers & acquisitions, equity financings, and other strategic opportunities. Prior to that, Nathan was in the equity capital markets group at J.P. Morgan in New York, covering healthcare and pricing more than ten initial public offerings.
Nathan holds a bachelor of science in business administration with concentrations in finance and accounting, magna cum laude, from the University of Richmond’s Robins School of Business.
This person is not in any offices
Norwest Venture Partners
2 followers
Norwest is a leading venture and growth equity investment firm managing more than $9.5 billion in capital. Since their inception, they have invested in more than 600 companies and partner with over 150 active companies currently in their venture and growth equity portfolio. The firm invests in early to late stage companies across a wide range of sectors with a focus on consumer, enterprise, and healthcare.